Research ArticleTheranostics
Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma
Narges K. Tafreshi, Christopher J. Tichacek, Darpan N. Pandya, Michael L. Doligalski, Mikalai M. Budzevich, HyunJoo Kil, Nikunj B. Bhatt, Nancy D. Kock, Jane L. Messina, Epifanio E. Ruiz, Nella C. Delva, Adam Weaver, William R. Gibbons, David C. Boulware, Nikhil I. Khushalani, Ghassan El-Haddad, Pierre L. Triozzi, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas and David L. Morse
Journal of Nuclear Medicine August 2019, 60 (8) 1124-1133; DOI: https://doi.org/10.2967/jnumed.118.217240
Narges K. Tafreshi
1Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Christopher J. Tichacek
1Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
2Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
3Department of Physics, University of South Florida, Tampa, Florida
Darpan N. Pandya
4Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina
Michael L. Doligalski
1Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Mikalai M. Budzevich
5Small Animal Imaging Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
HyunJoo Kil
6Department of Pharmaceutical Sciences, Health Sciences Center, West Virginia University, and Modulation Therapeutics Inc., Morgantown, West Virginia
Nikunj B. Bhatt
4Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina
Nancy D. Kock
7Section on Comparative Medicine, Department of Pathology, Wake Forest University Health Sciences, Winston-Salem, North Carolina
Jane L. Messina
8Departments of Anatomic Pathology and Cutaneous Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
9Department of Dermatology, University of South Florida, Tampa, Florida
10Department of Oncologic Sciences, University of South Florida, Tampa, Florida
Epifanio E. Ruiz
5Small Animal Imaging Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Nella C. Delva
1Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Adam Weaver
11Division of Research Integrity and Compliance, University of South Florida, Tampa, Florida
William R. Gibbons
11Division of Research Integrity and Compliance, University of South Florida, Tampa, Florida
David C. Boulware
12Biostatistics Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Nikhil I. Khushalani
13Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Ghassan El-Haddad
14Departments of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and
Pierre L. Triozzi
15Department of Hematology and Oncology, Wake Forest University Health Sciences, Winston-Salem, North Carolina
Eduardo G. Moros
1Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
2Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
3Department of Physics, University of South Florida, Tampa, Florida
10Department of Oncologic Sciences, University of South Florida, Tampa, Florida
Mark L. McLaughlin
6Department of Pharmaceutical Sciences, Health Sciences Center, West Virginia University, and Modulation Therapeutics Inc., Morgantown, West Virginia
Thaddeus J. Wadas
4Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina
David L. Morse
1Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
3Department of Physics, University of South Florida, Tampa, Florida
5Small Animal Imaging Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
10Department of Oncologic Sciences, University of South Florida, Tampa, Florida
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 8
August 1, 2019
Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma
Narges K. Tafreshi, Christopher J. Tichacek, Darpan N. Pandya, Michael L. Doligalski, Mikalai M. Budzevich, HyunJoo Kil, Nikunj B. Bhatt, Nancy D. Kock, Jane L. Messina, Epifanio E. Ruiz, Nella C. Delva, Adam Weaver, William R. Gibbons, David C. Boulware, Nikhil I. Khushalani, Ghassan El-Haddad, Pierre L. Triozzi, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas, David L. Morse
Journal of Nuclear Medicine Aug 2019, 60 (8) 1124-1133; DOI: 10.2967/jnumed.118.217240
Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma
Narges K. Tafreshi, Christopher J. Tichacek, Darpan N. Pandya, Michael L. Doligalski, Mikalai M. Budzevich, HyunJoo Kil, Nikunj B. Bhatt, Nancy D. Kock, Jane L. Messina, Epifanio E. Ruiz, Nella C. Delva, Adam Weaver, William R. Gibbons, David C. Boulware, Nikhil I. Khushalani, Ghassan El-Haddad, Pierre L. Triozzi, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas, David L. Morse
Journal of Nuclear Medicine Aug 2019, 60 (8) 1124-1133; DOI: 10.2967/jnumed.118.217240
Jump to section
Related Articles
Cited By...
- No citing articles found.